ProQR Therapeutics Creating RNA therapies for patients in need

ProQR scientist working in the lab

ProQR Community News

  • Exploring why companies partner their technology

    Community news

    Partnerships in our industry are very common as companies look to benefit from knowledge and resource sharing. In this blog we explore why companies, like ProQR, partner with other companies.

    Lenka in the Lab
  • Today marks an expansion of the ProQR and Lilly partnership

    Community news

    In September 2021 ProQR announced a global licensing and research collaboration with Lilly. The partnership focuses on developing potential medicines using our Axiomer RNA editing platform technology. Strategic collaborations like this can help to drive the advancement of an early-stage technology, like Axiomer, closer to the clinic.

    Axiomer partnership